# Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
Canonical URL: https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-proxy-materials-and-audited-financial-statements-for-the-2023-and-2024-fiscal-years
Ticker: EGRX
Company: Eagle Pharmaceuticals
Source: Eagle Pharmaceuticals
Published: 2025-09-17 20:43 EST
Original Source URL: https://investor.eagleus.com
## Summary

WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025 Annual Meeting of Stockholders, which is scheduled to be held virtually on October 17, 2025 at 10:00 a.m.

## Article Body
WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025 Annual Meeting of Stockholders, which is scheduled to be held virtually on October 17, 2025 at 10:00 a.m.
## Recent Company News
- 2026-01-14 15:21 EST — [Eagle Pharmaceuticals Announces Divestiture of Barhemsys](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-divestiture-of-barhemsys) — Source: Eagle Pharmaceuticals
- 2025-10-30 10:50 EST — [Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-board-extends-limited-duration-stockholder-rights-plan) — Source: Eagle Pharmaceuticals
- 2025-10-21 20:05 EST — [Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-results-of-2025-annual-meeting-of-stockholders) — Source: Eagle Pharmaceuticals
- 2025-10-15 20:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-second-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
- 2025-10-06 23:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-first-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)